In addition, the expression pattern of MRPL12, MRPL13 or POP1 were significantly associated with tumor stage (Figure 4D and Supplementary Table 6), suggesting that these three RBP-coding genes could be regarded as potential biomarkers for breast cancer prognosis. This evidence concerns the gene POP1 and neoplasm.